Articles by Cynthia Challener, PhD - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Articles by Cynthia Challener, PhD

Risk Reduction Top Driver for Biopharmaceutical Raw Material Development

Customers are looking to reduce risk, increase performance, and optimize productivity.
Aug 2, 2014

Customers are looking to reduce risk, increase performance, and optimize productivity.

Pharma Investments Reflect Key Industry Trends

Shrinking facility size, growth of biologics, and emerging market demand influence pharma investments.
Aug 2, 2014

Shrinking facility size, growth of biologics, and emerging market demand influence pharma investments.

Automating Online Sampling of Bioprocesses

The Modular Automated Sampling Technology platform consists of a sterile sampling system, a sample scheduler and navigator for automated sampling and delivery of samples to analytical instruments, and a data-management system.
Jul 2, 2014

The Modular Automated Sampling Technology platform allows sampling of bioreactors.

The Mainstreaming of Continuous Flow API Synthesis

The pharma industry is moving toward commercial-scale continuous processes for small-molecule API manufacturing.
Jul 2, 2014

The pharma industry is moving toward commercial-scale continuous processes for small-molecule API manufacturing.

Advances in Real-Time Bioreactor Sampling

The Modular Automated Sampling Technology platform takes online samples from bioreactors and transfers them directly to analytical devices.
Jun 18, 2014

The Modular Automated Sampling Technology platform takes online samples from bioreactors and transfers them directly to analytical devices.

Alternatives to Precious Metal Catalysts Sought

Industry seeks alternatives to costly and toxic precious metals used to form the catalysts for organic synthesis.
Jun 2, 2014

Industry seeks alternatives to costly and toxic precious metals used to form the catalysts for organic synthesis.

Seeking Alternative Catalyst Solutions

Transition metal-containing catalysts are widely used in organic synthesis, but many are based on expensive, rare metals. Researchers are seeking more sustainable alternatives.
Jun 2, 2014

Transition metal-containing catalysts are widely used in organic synthesis, but many are based on expensive, rare metals. Researchers are seeking more sustainable alternatives.

Cocrystals: Industry Takes a Wait-and-See Approach

The perceived risks associated with cocrystals may be slowing progress of their industrial application.
May 30, 2014

The perceived risks associated with cocrystals may be slowing progress of their industrial application.

HPAPIs: Fast-growing Segment Presents Challenges and Opportunities

Appropriate process design and engineering are critical for the production of small-molecule and biologic HPAPIs.
May 30, 2014

Appropriate process design and engineering are critical for the production of small-molecule and biologic HPAPIs.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerTargeting Different Off-Shore Destinations
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAsymmetric Synthesis Continues to Advance
Jill Wechsler Regulatory Watch Jill Wechsler Data Integrity Key to GMP Compliance
Sean Milmo European Regulatory WatchSean MilmoExtending the Scope of Pharmacovigilance Comes at a Price
FindPharma Custom Search
Click here